Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Glucagon analogues as long-acting GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis

Glucagon analogues as long-acting GLP-1/glucagon receptor agonists in the treatment of fatty liver disease and steatohepatitis

US Patent 11813312 · Granted Nov 14, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Glucagon analogues as long-acting GLP-1/glucagon receptor agonists in the treatm2025
Pharmaceutical composition, methods for treating and uses thereof2024
Bispecific anti-VEGF and anti-TrkB binding molecules for the treatment of eye di2024
Cyclopentathiophene carboxamide derivatives as platelet activating factor recept2023
Anti-NRP1A antibodies and their uses for treating eye or ocular diseases2023
Acylated glucagon analogue2022
Anti-Sema3A antibodies and their uses for treating eye or ocular diseases2022
Pharmaceutical composition, methods for treating and uses thereof2019
Acylated glucagon analogue2019
Glucagon analogues2019
Glucagon analogues2018
6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmac2016